Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer

OBJECTIVE: We evaluated the usefulness of human epididymis protein 4 (HE4), a tumor marker, during and after treatment in patients with ovarian cancer (OC). METHODS: We included Japanese patients newly diagnosed with OC treated at the National Cancer Center Hospital between 2014 and 2021. The HE4 le...

Descripción completa

Detalles Bibliográficos
Autores principales: Uno, Masaya, Matsuo, Rie, Maezawa, Naoki, Kato, Tomoyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375218/
https://www.ncbi.nlm.nih.gov/pubmed/37380167
http://dx.doi.org/10.5468/ogs.23024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375218/
https://www.ncbi.nlm.nih.gov/pubmed/37380167
http://dx.doi.org/10.5468/ogs.23024

Ejemplares similares